In other cardiac diseased models, such as pressure overload-induced cardiac hypertrophy [41], diabetic cardiomyopathy induced by type 1 diabetes [42] and doxorubicin-induced cardiomyopathy [43], MIF deficiency exacerbated the impaired cardiac function and lead to increased mortality. This evidence concerns the gene MIF and cardiac hypertrophy.